Author

Halil Kutlu Erol

University of Arizona College of Medicine-Tucson / Tulane University - Cited by 647 - Diabetes - Endocrinology - Obesity - Thyroid disorders - Nephrology

Biography

He is affiliated to Center for Diabetes & Obesity, Fatih University Hospital, Istanbul, Turkey. He is a recipient of many awards and grants for his valuable contributions and discoveries in major area of subject research. His international experience includes various programs, contributions and participation in different countries for diverse fields of study. His research interests reflect in his wide range of publications in various national and international journals.
Title
Cited by
Year
Leptin replacement improves cognitive development
GJ Paz-Filho, T Babikian, R Asarnow, K Esposito, HK Erol, ML Wong, ...PloS one 3 (8), e3098, 2008200
168
2008
Compatibility of different methods for the measurement of visceral fat in different body mass index strata
D Berker, S Koparal, S Isik, L Pasaoglu, Y Aydin, K Erol, T Delibasi, ...Diagn Interv Radiol 16 (2), 99-105, 2010201
138
2010
Changes in insulin sensitivity during leptin replacement therapy in leptin-deficient patients
G Paz-Filho, K Esposito, B Hurwitz, A Sharma, C Dong, V Andreev, ...American Journal of Physiology-Endocrinology and Metabolism 295 (6), E1401-E1408, 2008200
60
2008
Carotid intima-media thickness and its relations with the complications in patients with type 1 diabetes mellitus.
K Gül, İ Üstün, Y Aydın, D Berker, K Erol, M Ünal, AÖ Barazi, T Delibaşı, ...Anatolian Journal of Cardiology/Anadolu Kardiyoloji Dergisi 10 (1), 2010201
56
2010
Short-term plasticity of gray matter associated with leptin deficiency and replacement
ED London, SM Berman, S Chakrapani, T Delibasi, J Monterosso, ...The Journal of Clinical Endocrinology & Metabolism 96 (8), E1212-E1220, 2011201
47
2011
Congenital leptin deficiency and thyroid function
G Paz-Filho, T Delibasi, HK Erol, ML Wong, J LicinioThyroid Research 2 (1), 1-4, 2009200
42
2009
Neoadjuvant chemotherapy with cyclophosphamide, mitoxantrone, and 5-fluorouracil in locally advanced breast cancer
K Erol, E Baltali, K Altundag, N Guler, Y Ozisik, DA Onat, I Sayek, ...Onkologie (2), 81-85, 2005200
28
2005
Cellular immunity before and after leptin replacement therapy
GJ Paz-Filho, T Delibasi, HK Erol, ML Wong, J LicinioJournal of Pediatric Endocrinology and Metabolism 22 (11), 1069-1074, 2009200
21
2009
Effects of leptin on lipid metabolism
GJ Paz-Filho, A Ayala, K Esposito, HK Erol, T Delibasi, EH Barry, ...Hormone and metabolic research 40 (08), 572-574, 2008200
19
2008
Effects of leptin replacement on risk factors for cardiovascular disease in genetically leptin-deficient subjects
GJ Paz-Filho, D Andrews, K Esposito, HK Erol, T Delibasi, ML Wong, ...Hormone and metabolic research 41 (02), 164-167, 2009200
15
2009
Concomitant compression of median and ulnar nerves in a hemophiliac patient: a case report
B Kaymak, L Özçakar, A Çetin, K Erol, ZB ÖzçakarJoint Bone Spine 69 (6), 611-613, 2002200
14
2002
Herpes simplex type-2 encephalitis masked by diabetic ketoacidosis.
Y Aydin, I Ustun, K Erol, E Ozkaya, K Gul, D Berker, M Unal, T Delibasi, ...Journal of the National Medical Association 97 (5), 722, 2005200
13
2005
Autoimmune thyroid disease in patients with anti-GAD positive type 1 diabetes mellitus
K Gul, I Ustun, Y Aydin, D Berker, HK Erol, M Unal, AO Barazi, T Delibasi, ...Central European journal of medicine 4, 415-422, 2009200
6
2009
Lack of effectiveness of Bebtelovimab monoclonal antibody among high-risk patients with SARS-Cov-2 Omicron during BA.2, BA.2.12.1 and BA.5 subvariants dominated era
Lack of effectiveness of Bebtelovimab monoclonal antibody among high-risk patients with SARS-Cov- Omicron during BA., BA..1.1 and BA.5 subvariants dominated eraBT Srilekha Sridhara, Ahmet B. Gungor, Halil K. Erol, Mohanad Al-Obaidi ...PLOS ONE 18 (4), 030
2
2023
Leptin and insulin sensitivity: reply to Oral and Burant
G Paz-Filho, K Esposito, B Hurwitz, A Sharma, C Dong, V Andreev, ...American Journal of Physiology-Endocrinology and Metabolism 96 (), E396-E396, 00900
2
2009
Relapsed prolactinoma 27 years after conventional radiotherapy
S Köklü, AM Onat, K Erol, A Klçarslan, MK Altundag, I GüllüAmerican journal of clinical oncology 25 (4), 429-430, 2002200
1
2002